XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Restatement of Previously Issued Audited and Unaudited Financial Statements (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]  
Summary of Reconcilaition of the Financial Statements for the Affected Period
The following presents a reconciliation of the consolidated balance sheets, statements of operations and cash flows for the Affected Periods.
   
December 31, 2020
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet
             
Public warrants derivative liability
   —     161,456,462   161,456,462 
Private warrants derivative liability
   —     158,469,002   158,469,002 
Total liabilities
   16,852,448   319,925,464   336,777,912 
Class A common stock subject to possible redemption
   295,489,060   (295,489,060)   —   
Class A common stock
   186   2,955   3,141 
Additional
paid-in-capital
   9,210,213   287,169,386   296,379,599 
Accumulated deficit
   (4,211,183)   (311,608,745)   (315,819,928) 
Total stockholders’ equity (deficit)
   5,000,001   (24,436,404)   (19,436,403) 
Statement of Operations for the year ended December 31, 2020
             
Change in fair value of warrant liabilities
   —     (310,330,174)   (310,330,174) 
Loss before income tax expense
   (4,789,152)   (310,330,174)   (315,119,326) 
Net loss
   (4,990,755)   (310,330,174)   (315,320,929) 
Basic and diluted net loss per Class B common stock
   (0.73)   (39.52)   (40.25) 
Statement of Cash Flows for the year ended December 31, 2020
             
Net loss
   (4,990,755)   (310,330,174)   (315,320,929) 
Change in fair value of warrant liabilities
   —     310,330,174   310,330,174 

   
September 30, 2020
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet (unaudited)
             
Public warrants derivative liability
   —     49,107,054   49,107,054 
Private warrants derivative liability
   —     32,522,036   32,522,036 
Total liabilities
   12,158,095   81,629,090   93,787,185 
Class A common stock subject to possible redemption
   300,029,150   (81,629,090)   218,400,060 
Class A common stock
   141   816   957 
Additional
paid-in-capital
   4,670,168   73,311,555   77,981,723 
Retained earnings (Accumulated deficit)
   328,914   (73,312,371)   (72,983,457) 
Total stockholders’ equity
   5,000,008   —     5,000,008 
Statement of Operations for the three months ended September 30, 2020 (unaudited)
             
Change in fair value of warrant liabilities
   —     (68,996,330)   (68,996,330) 
Loss before income tax expense
   (787,652)   (68,996,330)   (69,783,982) 
Net loss
   (792,915)   (68,996,330)   (69,789,245) 
Basic and diluted net loss per Class B common stock
   (0.10)   (8.79)   (8.89) 
Statement of Operations for the nine months ended September 30, 2020 (unaudited)
             
Change in fair value of warrant liabilities
   —     (72,033,800)   (72,033,800) 
Loss before income tax expense
   (208,400)   (72,033,800)   (72,242,200) 
Net loss
   (450,658)   (72,033,800)   (72,484,458) 
Basic and diluted net loss per Class B common stock
   (0.15)   (9.17)   (9.32) 
Statement of Cash Flows for the nine months ended September 30, 2020 (unaudited)
             
Net loss
   (450,658)   (72,033,800)   (72,484,458) 
Change in fair value of warrant liabilities
   —     72,033,800   72,033,800 
 
   
June 30, 2020
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet (unaudited)
             
Public warrants derivative liability
   —     8,270,721   8,270,721 
Private warrants derivative liability
   —     4,362,039   4,362,039 
Total liabilities
   11,905,001   12,632,760   24,537,761 
Class A common stock subject to possible redemption
   300,822,070   (12,632,760)   288,189,310 
Class A common stock
   133   126   259 
Additional
paid-in-capital
   3,877,256   4,315,915   8,193,171 
Retained earnings (Accumulated deficit)
   1,121,829   (4,316,041)   (3,194,212) 
Total stockholders’ equity
   5,000,003   —     5,000,003 
Statement of Operations for the three months ended June 30, 2020 (unaudited)
             
Change in fair value of warrant liabilities
   —     (2,685,170)   (2,685,170) 
Loss before income tax expense
   (96,889)   (2,685,170)   (2,782,059) 
Net loss
   (124,174)   (2,685,170)   (2,809,344) 
Basic and diluted net loss per Class B common stock
   (0.02)   (0.34)   (0.36) 
Statement of Operations for the six months ended June 30, 2020 (unaudited)
             
Change in fair value of warrant liabilities
   —     (3,037,470)   (3,037,470) 
Income (loss) before income tax expense
   579,252   (3,037,470)   (2,458,218) 
Net income (loss)
   342,257   (3,037,470)   (2,695,213) 
Basic and diluted net loss per Class B common stock
   (0.06)   (0.39)   (0.45) 
Statement of Cash Flows for the six months ended June 30, 2020 (unaudited)
             
Net income (loss)
   342,257   (3,037,470)   (2,695,213) 
Change in fair value of warrant liabilities
   —     3,037,470   3,037,470 

 
   
March 31, 2020
 
   
As
Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet (unaudited)
             
Public warrants derivative liability
   —     6,524,218   6,524,218 
Private warrants derivative liability
   —     3,423,372   3,423,372 
Total liabilities
   11,877,840   9,947,590   21,825,430 
Class A common stock subject to possible redemption
   300,946,240   (9,947,590)   290,998,650 
Class A common stock
   132   99   231 
Additional
paid-in-capital
   3,753,087   1,630,772   5,383,859 
Retained earnings (Accumulated deficit)
   1,246,003   (1,630,871)   (384,868) 
Total stockholders’ equity
   5,000,007   —     5,000,007 
Statement of Operations for the three months ended March 31, 2020 (unaudited)
             
Change in fair value of warrant liabilities
   —     (352,300)   (352,300) 
Income before income taxes
   676,141   (352,300)   323,841 
Net income
   466,431   (352,300)   114,131 
Basic and diluted net loss per Class B common stock
   (0.03)   (0.04)   (0.07) 
Statement of Cash Flows for the three months ended March 31, 2020 (unaudited)
             
Net income
   466,431   (352,300)   114,131 
Change in fair value of warrant liabilities
   —     352,300   352,300 

   
December 31, 2019
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet
             
Public warrants derivative liability
   —     6,282,349   6,282,349 
Private warrants derivative liability
   —     3,312,941   3,312,941 
Total liabilities
   11,692,080   9,595,290   21,287,370 
Class A common stock subject to possible redemption
   300,479,810   (9,595,290)   290,884,520 
Class A common stock
   136   96   232 
Additional
paid-in-capital
   4,219,513   1,278,475   5,497,988 
Retained earnings (Accumulated deficit)
   779,572   (1,278,571)   (498,999) 
Total stockholders’ equity
   5,000,006   —     5,000,006 
Statement of Operations for the
 
period from May 19, 2019 (inception) through December 31, 2019
             
Change in fair value of warrant liabilities
   —     (959,526)   (959,526) 
Allocated expense for warrant issuance cost
   —     (319,045)   (319,045) 
Income (loss) before income taxes
   1,258,636   (1,278,571)   (19,935) 
Net income (loss)
   779,572   (1,278,571)   (498,999) 
Basic and diluted net loss per Class B common stock
   (0.12)   (0.16)   (0.28) 
Statement of Cash Flows for the
period from May 19, 2019 (inception) through December 31, 2019
             
Net income (loss)
   779,572   (1,278,571)   (498,999) 
Issuance costs related to warrant liability
   —     319,045   319,045 
Change in fair value of warrant liabilities
   —     959,526   959,526 

   
September 30, 2019
 
   
As
Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet (unaudited)
             
Public warrants derivative liability
   —     9,947,060   9,947,060 
Private warrants derivative liability
   —     4,858,980   4,858,980 
Total liabilities
   11,406,919   14,806,040   26,212,959 
Class A common stock subject to possible redemption
   299,838,630   (14,806,040)   285,032,590 
Class A common stock
   143   148   291 
Additional
paid-in-capital
   4,860,686   6,489,173   11,349,859 
Retained earnings (Accumulated deficit)
   138,392   (6,489,321)   (6,350,929) 
Total stockholders’ equity
   5,000,006   —     5,000,006 
Statement of Operations for the three months ended September 30, 2019 (unaudited)
             
Change in fair value of warrant liabilities
   —     (6,170,276)   (6,170,276) 
Allocated expense for warrant issuance cost
   —     (319,045)   (319,045) 
Income (loss) before income tax expense
   388,196   (6,489,321)   (6,101,125) 
Net income (loss)
   194,611   (6,489,321)   (6,294,710) 
Basic and diluted net loss per Class B common stock
   (0.07)   (0.83)   (0.90) 
Statement of Operations for the period from May 10, 2019 (inception) through September 30, 2019 (unaudited)
             
Change in fair value of warrant liabilities
   —     (6,170,276)   (6,170,276) 
Allocated expense for warrant issuance cost
   —     (319,045)   (319,045) 
Income (loss) before income tax expense
   331,977   (6,489,321)   (6,157,344) 
Net income (loss)
   138,392   (6,489,321)   (6,350,929) 
Basic and diluted net loss per Class B common stock
   (0.08)   (0.83)   (0.91) 
Statement of Cash Flows for the period from May 10, 2019 (inception) through September 30, 2019 (unaudited)
             
Net income (loss)
   138,392   (6,489,321)   (6,350,929) 
Issuance costs related to warrant liability
   —     319,045   319,045 
Change in fair value of warrant liabilities
   —     6,170,276   6,170,276 
 
   
July 30, 2019
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet
             
Public warrants derivative liability
   —     5,400,000   5,400,000 
Private warrants derivative liability
   —     2,880,000   2,880,000 
Total liabilities
   11,443,548   8,280,000   19,723,548 
Class A common stock subject to possible redemption
   285,849,880   (8,280,000)   277,569,880 
Class A common stock
   142   83   225 
Additional
paid-in-capital
   5,175,033   305,917   5,480,950 
Accumulated deficit
   (176,030)   (306,000)   (482,030) 
Total stockholders’ equity
   5,000,008   —     5,000,008